Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could ...

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...

In regard to what’s happening now with NIH, the main thing to do is diversify. You raise both non-dilutive funding through ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers discovered a key process where malarial parasites take up a human blood cell ...

While PD-1/PD-L1 blockade has demonstrated remarkable clinical successes, recent studies suggest that its novel target has a ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

Variations in regulatory requirements across regions often create inefficiencies in drug development—for example, differences in manufacturing standards and stability testing protocols can lead ...